Posted by herpills on October 25, 2012, at 8:25:23
In reply to Re: General healthchecks unlikely To Benefit Patients, posted by jono_in_adelaide on October 24, 2012, at 18:24:47
> Cost effectiveness means you use the cheap first line drugs forst (for example, sertaline which costs $4 per month) and reserve the ones costing $400 per month for resistant cases.
>
> It means insurance doesnt accept paying $400 per month for the latest drug when it hasnt been shown to be any more effective than the old cheap ones.
>
> It means prescribing a good quality generic for $10 rather than a brand name for $100
>
> I dont see anything wrong with any of theseNothing wrong with this approach, but the problem is how do we determine when the $4 generic is ditched for something that will be more effective? How long does a patient have to suffer on an ineffective treatment until they are given the green light to try the next, more expensive agent? herpills
this signature | Show by default | Change to hide (next time)
poster:herpills
thread:1029529
URL: http://www.dr-bob.org/babble/20121018/msgs/1029739.html